Yo, check out this massive move in the Ebola fight. Moderna just snagged $50 million from CEPI to jump on the Bundibugyo ebolavirus vaccine development.<br> <br> Seriously, the situation in the DRC is getting brutal. This isn't just some routine vaccine rollout; they're *urgently* accelerating everything because the outbreak is totally out of control. The cool part is that Moderna is leveraging their mRNA platform, the same tech that basically saved us during COVID. This speed is key when dealing with emerging threats like this.<br> <br> It's awesome that CEPI isn't putting all their eggs in one basket. They're also backing the AIDS Vaccine Initiative (for the Zaire strain) and Oxford/Serum Institute (using adenovirus tech), which shows a smart, multi-pronged approach to catching these diseases. The fact that there are *zero* licensed options specifically for the Bundibugyo strain is a huge gap, and this funding is going straight toward filling it.<br> <br> Moderna's CEO basically nailed it: mRNA is the future for rapid response. If this vaccine hits the right targets, it could be the game-changer here. Fingers crossed this gets deployed fast before the situation spirals further.<br> <br> Source: https://arstechnica.com/health/2026/06/moderna-gets-50-million-to-develop-mrna-ebola-vaccine-against-bundibugyo/